Government of Saskatchewan to cover Elahere and Keytruda for eligible ovarian cancer patients from Dec 1, 2026
Government of Saskatchewan will fund Elahere and Keytruda for ovarian cancer patients from Dec 1, 2026; about eight to 10 people a year may benefit.
For newcomers, students, workers, employers and families in Saskatchewan, expanded coverage for Elahere and Keytruda from Dec 1, 2026 strengthens access to innovative ovarian cancer care close to home.
Health care workers are in demand across Canada. See if your occupation qualifies with the FREE evaluation: Occupation eligibility (NOC) (https://gloppap.com/evaluate/noc). Questions? Your Canadian AR, Joy Stephen (résumé: https://polinsys.co/joy), answers them at the FREE Q&A every Friday — join at https://myar.me/zoom.
Call Polinsys toll-free: 1-888-553-4833.